Every year, over one million people worldwide undergo open-heart surgery in the fight against cardiovascular disease. American Heart Association reports that each year in the United States, over 700,000 open-heart surgeries are performed requiring mid-line sternotomies.

In December 2020, Zimmer Biomet, a global leader in musculoskeletal healthcare announced the acquisition of the A&E Medical Corporation. Zimmer Biomet can now offer a complete portfolio of sternal closure devices – including sternal sutures, cable systems, and rigid fixation – along with a range of single-use complementary temporary pacing wire and surgical punch products.

"We believe the addition of A&E's leading comprehensive sternal closure products to the portfolio of Zimmer Biomet, a long-standing leader in surgical solutions, will benefit surgeons, patients and health care systems," said Thomas J. Sullivan, President & Chief Executive Officer of A&E Medical Corporation.

Zimmer Biomet is now able to offer a continuum of care to patients undergoing heart surgery with a robust portfolio of cardio-thoracic products.